华邦健康(002004) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥2,881,914,754.42, representing a 6.37% increase year-over-year[4] - Net profit attributable to shareholders decreased by 14.73% to ¥167,515,841.88 for the same period[4] - The net profit excluding non-recurring gains and losses fell by 24.71% to ¥133,696,578.33[4] - Total operating revenue for the current period reached ¥8,629,345,347.58, an increase of 9.4% compared to ¥7,887,624,026.14 in the previous period[25] - Net profit attributable to the parent company was ¥520,605,679.12, compared to ¥513,917,103.82 in the same period last year, indicating a slight increase of about 1.3%[31] - Operating profit for the period was ¥923,649,475.63, showing a marginal increase from ¥922,759,638.29 in the previous year[30] - The company reported a total comprehensive income of ¥721,527,099.20, up from ¥585,649,826.03, marking an increase of approximately 23.1%[31] Assets and Liabilities - The total assets at the end of the reporting period were ¥29,947,839,816.05, an increase of 6.10% compared to the end of the previous year[4] - The company's total liabilities as of September 30, 2021, were not explicitly stated but are implied to have changed in relation to the asset growth[18] - Total liabilities increased to ¥15,126,327,553.39 from ¥14,089,427,152.31, reflecting a growth of 7.4%[23] - The company's equity attributable to shareholders rose to ¥9,851,142,829.68, up from ¥9,629,493,730.58, a growth of 2.3%[23] - Current liabilities totaled ¥11,720,804,709.21, including short-term borrowings of ¥6,709,154,966.64 and accounts payable of ¥1,010,034,167.07[41] Cash Flow - Cash flow from operating activities for the year-to-date was ¥798,903,991.74, a decrease of 51.68% compared to the same period last year[4] - The net cash flow from operating activities was $798.9 million, a decrease of 51.7% compared to $1.65 billion in the previous period[35] - The total cash inflow from investment activities was $5.98 billion, down 7.2% from $6.45 billion year-over-year[35] - The net cash flow from financing activities was -$202.3 million, a significant decline from a positive $1.58 billion in the previous year[35] - The total cash and cash equivalents at the end of the period amounted to $2.64 billion, a decrease from $3.82 billion in the prior year[35] Investments and Expenditures - Investment income increased by 56.35% to ¥192,098,131.88, primarily due to higher returns from joint ventures[10] - The company has invested ¥2,870,725.43 in development expenditures, significantly higher than ¥1,483,602.28 in the previous period, reflecting an increase of 93.5%[21] - Long-term equity investments stood at $2.36 billion, unchanged from the previous period[38] Shareholder Information - The total number of common shareholders at the end of the reporting period is 94,257, with the largest shareholder, Tibet Huibang Technology Co., Ltd., holding 18.71% of shares, equating to 370,449,804 shares[11] - Shareholders' equity totaled ¥14,136,682,510.39, with total equity attributable to the parent company at ¥9,629,493,730.58[44] Operational Efficiency - The weighted average return on equity was 1.73%, down by 0.34% from the previous year[4] - The company reported a significant increase in prepayments, rising by 52.77% to ¥274,075,525.61[7] - The company’s strategic focus includes the completion of board and supervisory committee elections, enhancing governance and operational efficiency[15] Other Financial Metrics - Research and development expenses totaled ¥221,884,196.23, down from ¥238,363,372.64, representing a decrease of approximately 6.3%[30] - Financial expenses decreased significantly to ¥305,908,679.72 from ¥417,712,946.13, a reduction of about 26.7%[30] - Other comprehensive income after tax was ¥5,527,816.81, a significant recovery from a loss of ¥124,877,784.83 in the previous period[30] - The company reported a deferred income of ¥242,488,330.54, compared to ¥224,944,362.25 in the previous period, showing an increase of 7.8%[23] Compliance and Standards - The company has not audited its third-quarter report for 2021[45] - The company has implemented new leasing standards starting from 2021, affecting prior comparative data[45]